Oncolytics Biotech Inc (ONC)

1.26
-0.05(-3.82%)
  • Volume:
    3,506
  • Bid/Ask:
    1.26/1.29
  • Day's Range:
    1.26 - 1.29
  • Type:Equity
  • Market:Canada
  • ISIN:CA6823108759
  • CUSIP:682310875

ONC Overview

Prev. Close
1.31
Day's Range
1.26-1.29
Revenue
-
Open
1.26
52 wk Range
1.06-3.55
EPS
-0.48
Volume
3,506
Market Cap
74.44M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
33,055
P/E Ratio
-
Beta
1.73
1-Year Change
-63.16%
Shares Outstanding
57,790,158
Next Earnings Date
Aug 05, 2022
What is your sentiment on Oncolytics Biotech?
or
Market is currently closed. Voting is open during market hours.

Oncolytics Biotech Inc News

Oncolytics Biotech Inc Analysis

Oncolytics Biotech Inc Company Profile

Oncolytics Biotech Inc Company Profile

Employees
0
Market
Canada

Oncolytics Biotech Inc. is a biotechnology company, which is engaged in developing pelareorep, an intravenously delivered immunotherapeutic agent. The Company is focused on the discovery and development of pharmaceutical products for the treatment of cancers. Its lead product, Pelareorep, is a systemically administered immuno-oncology (I-O) viral agent with the potential to treat a variety of cancers. Pelareorep’s anti-tumor activity is based on three modes: selective viral replication in permissive cancer cells, which leads to tumor cell lysis; activation of innate immunity in response to the infection, which results in a cascade of chemokines/cytokines, causing natural killer (NK) cells to be activated and attack cancer cells; and specific adaptive immune response triggered by tumor and viral-associated antigens displayed by antigen presenting cells (APCs), infected tumor cells and dendritic cells to T cells.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Any major news in the pipeline as this is going up last couple days?
    0
    • https://usanewsgroup.com/2020/02/24/why-biotechnology-companies-are-so-important/
      0
      • Pfizer are working with ONCY and they are collaborating with each other. Good news will come here!!!
        0
        • Their tech stack and team are very strong. Be patient guys!!
          0
          • Long Term looks strong technically
            0
            • but now
              0